Tag #Mounjaro

Showing 37 to 40 of 40 results

bbc.com

🌐 85% Global Worthiness

Jan 13, 10:05

NHS Weight-Loss Jab: High Cost Limits Access for Millions

Ray, 62, lost over two stone in five months using Wegovy via the NHS, but limited funding means only a tiny percentage of the 3.4 million eligible patients in England can access such treatments; the annual cost per patient is around £3,000.

NHS Weight-Loss Jab: High Cost Limits Access for Millions

Ray, 62, lost over two stone in five months using Wegovy via the NHS, but limited funding means only a tiny percentage of the 3.4 million eligible patients in England can access such treatments; the annual cost per patient is around £3,000.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the cost of weight-loss drugs like Wegovy on NHS accessibility and patient care?

Wegovy", a weight-loss injection, has enabled Ray, a 62-year-old, to lose over two stone in five months. However, NHS access is limited to two years per patient due to cost constraints, impacting millions of eligible individuals. The high cost of these treatments, approximately £3,000 annually per patient, would strain the NHS budget if widely implemented.

theguardian.com

🌐 75% Global Worthiness

Dec 5, 10:08

England's NHS Announces 12-Year Rollout Plan for Mounjaro Weight-Loss Drug

The National Institute for Health and Care Excellence (NICE) announced a 12-year rollout plan for the weight-loss drug Mounjaro on the NHS in England, prioritizing 220,000 patients in the first three years due to budgetary constraints, affecting 3.4 million eligible individuals.

England's NHS Announces 12-Year Rollout Plan for Mounjaro Weight-Loss Drug

The National Institute for Health and Care Excellence (NICE) announced a 12-year rollout plan for the weight-loss drug Mounjaro on the NHS in England, prioritizing 220,000 patients in the first three years due to budgetary constraints, affecting 3.4 million eligible individuals.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How will the NHS manage the demand for Mounjaro, given its high cost and limited initial availability?

NICE prioritizes patients with the highest clinical needs, primarily those receiving care from specialist weight management services. This phased rollout aims to balance the benefits of Mounjaro—shown to cause 20.2% weight loss in trials—with the financial burden on the NHS. The 12-year plan, requested by NHS England, allows for a review in three years to assess the drug's impact and adjust the rollout accordingly.

dailymail.co.uk

🌐 85% Global Worthiness

Dec 11, 22:09

GLP-1 Weight Loss Drugs May Reduce Breast Cancer Treatment Efficacy

A study of hundreds of women with triple-negative breast cancer found that those taking GLP-1 weight-loss drugs like Ozempic and Wegovy had significantly lower remission rates (28% vs 63%) after treatment, suggesting interference with chemotherapy and immunotherapy effectiveness.

GLP-1 Weight Loss Drugs May Reduce Breast Cancer Treatment Efficacy

A study of hundreds of women with triple-negative breast cancer found that those taking GLP-1 weight-loss drugs like Ozempic and Wegovy had significantly lower remission rates (28% vs 63%) after treatment, suggesting interference with chemotherapy and immunotherapy effectiveness.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the impact of GLP-1 weight loss drugs on the efficacy of breast cancer treatments?

A new study shows that GLP-1 weight loss drugs, like Ozempic and Wegovy, may negatively impact the effectiveness of breast cancer treatments. In a study of hundreds of women with triple-negative breast cancer, only 28% of those taking GLP-1 drugs achieved complete cancer remission after treatment, compared to 63% of those not taking the drugs. This suggests a potential interference with chemotherapy and immunotherapy.

arabic.cnn.com

🌐 60% Global Worthiness

Nov 21, 13:06

Weight-Loss Drugs: Successes and Side Effects

This article examines the experiences of three individuals who used GLP-1 receptor agonist medications for weight loss, highlighting both the positive and negative aspects of these drugs.

Weight-Loss Drugs: Successes and Side Effects

This article examines the experiences of three individuals who used GLP-1 receptor agonist medications for weight loss, highlighting both the positive and negative aspects of these drugs.

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the common side effects associated with GLP-1 receptor agonist medications for weight loss?

The provided text does not describe a 13-year-old weighing 167 kilograms taking weight-loss medication, so I cannot answer this question.

Showing 37 to 40 of 40 results